TMIST (Tomosynthesis Mammographic Imaging Screening Trial)
TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1096919.htm
- Syndication ID: 19467
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:13 PM
- Date Syndication Updated: Monday, May 03, 2021 at 09:13 AM
Embed Code Snippet
To get the embed code snippet please Login.
